Cabozantinib for Advanced or Metastatic Cervical Carcinoma After Platinum Treatment Failure

Clinical trial NCT04205799 · COMPLETED

Trial details

NCT number: NCT04205799
Sponsor: Centre Francois Baclesse
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced/Metastatic Cervical Cancer

Start date: 2020-01-15
Primary completion: 2023-01-15
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.